Recombinant human α‐interferon in patients with chronic non‐A, non‐B hepatitis: A multicenter randomized controlled trial from France
Patrick Marcellin, Nathalie Boyer, Emile Giostra, Claude Degott, Anne Marie Courouce, FrançOise Degos, Henri Coppere, Paul Cales, Patrice Couzigou, Jean‐Pierre Benhamou – 1 March 1991 – We have conducted a multicenter randomized controlled trial comparing two doses of recombinant human α‐interferon for efficacy in 60 patients with chronic non‐A, non‐B hepatitis. The source of infection appeared to be transfusion in 30 patients, intravenous drug abuse in 16 patients and was unknown in 14 patients.